View Comments
Mississippi hospitals are becoming increasingly stressed as the COVID-19 delta variant surges and health care workers experience high rates of burnout, state health officials said during a livestreamed discussion Friday.
The 1,317 new COVID-19 cases reported on Friday were the highest for one day since January, according to the Mississippi State Department of Health. State Health Officer Thomas Dobbs has associated the spike in cases with the delta variant.
Dobbs said over 90% of coronavirus-related hospitalizations were in unvaccinated people, noting one Mississippi hospital told him they were so busy, they had to put two patients in a closet. Other larger hospitals are already using emergency rooms as overflow ICUs, he said.
Humboldt County Public Health reported 14 new COVID-19 cases today and an additional hospitalization, a resident in their 60s. Today's case results came after laboratories.
FDA to Add Warning Label on Pfizer Vaccine Related to Heart Inflammation mediaite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mediaite.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
BRIDGEWATER, N.J. and KENILWORTH, N.J., June 1, 2021 /PRNewswire/ Vaxelis™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed as part of a partnership between Sanofi Pasteur, the global vaccines business unit of Sanofi, and Merck (NYSE: MRK), known as MSD outside the United States and Canada, is now available in the U.S.
Vaxelis is the first and only hexavalent (six-in-one) combination vaccine available in the U.S. Vaxelis is a vaccine given to protect your child from getting diphtheria, tetanus (lockjaw), pertussis (whooping cough), polio, Hib (
This Combination Vaccine May Simplify Execution and Reduce Shots Needed to Complete CDC’s Recommended Child and Adolescent Immunization Schedule VAXELIS™ developed as part of a U.S.-based partnership between Merck known as MSD outside the United States and Canada, and Sanofi Pasteur, the global vaccines business unit of Sanofi, is now available in the U.S. VAXELIS is the first and only hexavalent combination .